TITLE:
Dose Confirmation Efficacy Study (V260-007)

CONDITION:
Rotavirus Infections

INTERVENTION:
RotaTeq, rotavirus vaccine, live, oral, pentavalent

SUMMARY:

      This study was designed to evaluate the safety of the investigational Rotavirus Vaccine and
      the efficacy to prevent Rotavirus Gastroenteritis.
    

DETAILED DESCRIPTION:

      The duration of treatment is 10 months.
    

ELIGIBILITY:
Gender: All
Age: 6 Weeks to 12 Weeks
Criteria:

        Inclusion Criteria:

          -  Healthy infants

        Exclusion Criteria:

          -  History of abdominal disorders from a birth defect, intussusception, or abdominal
             surgery

          -  Known or suspected problems with immune system

          -  Fever at time of immunization

          -  Prior administration of a rotavirus vaccine

          -  History of known prior rotavirus disease

          -  Chronic diarrhea, or failure to thrive
      
